1 – 10 of 40
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Response to the Letter regarding the EBIOM-D-23-04056 : “CPAP may promote an endothelial inflammatory milieu in sleep apnoea after coronary revascularization”
(
- Contribution to journal › Letter
-
Mark
CPAP may promote an endothelial inflammatory milieu in sleep apnoea after coronary revascularization
(
- Contribution to journal › Article
-
Mark
Childhood screening for type 1 diabetes comparing automated multiplex Antibody Detection by Agglutination-PCR (ADAP) with single plex islet autoantibody radiobinding assays
(
- Contribution to journal › Article
-
Mark
Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology : a post hoc analysis of the “ADAMANT” randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial
(
- Contribution to journal › Article
-
Mark
Accelerometer-based physical activity is associated with the gut microbiota in 8416 individuals in SCAPIS
(
- Contribution to journal › Article
-
Mark
A 14-gene B-cell immune signature in early-stage triple-negative breast cancer (TNBC) : a pooled analysis of seven studies
(
- Contribution to journal › Article
-
Mark
The anti-leprosy drug clofazimine reduces polyQ toxicity through activation of PPARγ
(
- Contribution to journal › Article
- 2023
-
Mark
Centrally and peripherally altered glucose transporters : is it time to revisit energy deficiency as a potential treatment strategy in Huntington's disease?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
(
- Contribution to journal › Article
-
Mark
Oral fungal profiling and risk of nasopharyngeal carcinoma : a population-based case-control study
(
- Contribution to journal › Article